Wasim(Sheikh)AhmedMD

PubMed

• Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 ...
  Pitkin, D. H., Sheikh, W., Nadler, H. L.> ;Clin Infect Dis. 1997 Feb
• Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
  Iaconis, J. P., Pitkin, D. H., Sheikh, W., Nadler, H. L.> ;Clin Infect Dis. 1997 Feb
• A compilation of meropenem tissue distribution data.
  Hutchison, M., Faulkner, K. L., Turner, P. J., Haworth, S. J., Sheikh, W., Nadler, H., Pitkin, D. H.> ;J Antimicrob Chemother. 1995 Jul
• A comparison of the in vitro postantibiotic effect of meropenem and imipenem versus selected enterobacteriaceae and other pathogens.
  Nadler, H. L., Sheikh, W.> ;Diagn Microbiol Infect Dis. 1993 Jul
• Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers.
  Sheikh, W., Pitkin, D. H., Nadler, H.> ;Clin Infect Dis. 1993 Jun
• Comparison of sensititre broth microdilution and agar dilution susceptibility testing techniques for meropenem to determine accuracy, reproducibility, and predictive v...
  Dowzicky, M. J., Nadler, H. L., Sheikh, W.> ;J Clin Microbiol. 1994 Sep
• Comparison of the activity of meropenem with that of other agents in the treatment of intraabdominal, obstetric/gynecologic, and skin and soft tissue.
  Pitkin, D., Sheikh, W., Wilson, S., Hemsell, D., Nichols, R., Nadler, H., Dowzicky, M.> ;Clin Infect Dis. 1995 Jun
• Potential factors influencing carbapenem activity against Bacteroides fragilis group isolates.
  Iaconis, J. P., Nadler, H. L., Sheikh, W.> ;Clin Infect Dis. 1995 Jun
• Are all carbapenems created equal?
  Iaconis, J. P., Nadler, H. L., Pitkin, D. H., Sheikh, W.> ;J Antimicrob Chemother. 1994 Sep
• Development and validation of a neutralizer system for in vitro evaluation of some antiseptics.
  Sheikh, W.> ;Antimicrob Agents Chemother. 1981 Mar
• A new selective medium for isolating Pseudomonas spp. from water.
  Krueger, C. L., Sheikh, W.> ;Appl Environ Microbiol. 1987 Apr
• A multicenter study of the in vitro antianaerobic activity of cefotetan compared with other antimicrobial agents.
  Zabransky, R. J., Bobey, D. G., Sheikh, W.> ;Am J Surg. 1988 May 31
• Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay.
  Pitkin, D. H., Sheikh, W., Nadler, H.> ;J Antimicrob Chemother. 1989 Sep
• Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.
  Zabransky, R. J., Bobey, D. G., Barry, A. L., Allen, S. D., Fuchs, P. C., Gerlach, E. H., Thornsberry, C., Sheikh, W., Jones, R. N.> ;J Clin Microbiol. 1989 Jan
• The postantibiotic effect of meropenem and imipenem on selected bacteria.
  Nadler, H. L., Pitkin, D. H., Sheikh, W.> ;J Antimicrob Chemother. 1989 Sep
• Lack of predictability of cefotetan in vitro susceptibility tests against cefotetan-resistant anaerobic bacteria in determining clinical and bacteriologic efficacies.
  Sheikh, W., Bobey, D. G.> ;Diagn Microbiol Infect Dis. 1992 Sep 01
• Join now to see all